NAT UNIVERSITY CORP ASAHIKAWA MEDICAL UNIVERSITY has a total of 15 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, computer technology and biotechnology are ROBARTS RES INST, CT HOSPITALIER UNIVERSITAIRE VAUDOIS CHUV and FUNDACION PARA LA INVESTIG BIOMEDICA DEL HOSPITAL GREGORIO MARANON.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 11 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Computer technology | |
#3 | Biotechnology | |
#4 | Foods and drinks | |
#5 | Medical technology | |
#6 | IT methods for management | |
#7 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Image data processing | |
#5 | Diagnosis and surgery | |
#6 | Healthcare informatics | |
#7 | Special foods | |
#8 | Foods | |
#9 | Analysing materials | |
#10 | Data processing systems |
# | Name | Total Patents |
---|---|---|
#1 | Kohgo Yutaka | 6 |
#2 | Mizukami Yusuke | 3 |
#3 | Okizaki Atsutaka | 3 |
#4 | Aburano Tamio | 3 |
#5 | Yoshida Akitoshi | 2 |
#6 | Sasajima Junpei | 2 |
#7 | Segawa Syuichi | 2 |
#8 | Ueno Nobuhiro | 2 |
#9 | Sugiyama Yoshiaki | 2 |
#10 | Fujiya Mikihiro | 2 |
Publication | Filing date | Title |
---|---|---|
WO2016027469A1 | Splicing variant of hepcidin, and method for diagnosing cancer utilizing said variant as measure | |
WO2015041312A1 | Method and system for image processing of intravascular hemodynamics | |
WO2013118786A1 | Immortalized cell lines of capillary vessel-forming cells in peripheral tissue | |
WO2012020566A1 | Highly functionalized stem cell/progenitor cell by ape1 gene transfection | |
EP2559437A1 | Intestinal protectant | |
EP2418272A1 | New revascularization cells derived from mononuclear cells, and method of inducing differentiation thereof | |
EP2163250A1 | Anticancer therapy by transplanting vascular endothelial progenitor cells |